ArticleBlood advances2021

DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes.

Kensuke Kayamori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.